Home›People›Michael Bielski
Michael Bielski

Michael Bielski

President & Chief Executive Officer, director at Spearhead Bio. Also a chief executive officer and director at Metablify and a director at NewLeaf Symbiotics.

ExecutiveDirectorRoles at 3 startups
Updated Nov 10, 2026·Latest SEC filing Jun 23, 2026·Suggest an edit

About Michael Bielski

Michael Bielski is a president & chief executive officer, director at Spearhead Bio.

Form D filings also name Michael Bielski as a chief executive officer and director at Metablify and a director at NewLeaf Symbiotics.

Michael Bielski first appears on SEC filings in 2013.

Experience

This experience comes from Michael Bielski's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Bielski in the role, so the role may have started earlier or lasted longer.

Spearhead Bio, Inc. Current
President and CEO (2025 – Present)
Director
2025 – Present · Saint Louis, MO
Spearhead Bio develops crop gene-editing tools for seed companies and crop developers.
Metablify, Inc. Current
Co-Founder, President and CEO (2024 – Present)
Director
2024 – Present · St. Louis, MO
Dukal, LLC Current
Director of Innovation
2019 – Present
Capseus Current
Co-Founder, President and CEO
2014 – Present
DevTech Partners Current
Founder and President
2009 – Present
Center for Biotechnology, NYS Center for Advanced Technology Current
Entrepreneur-in-Residence
2008 – Present
Hairpin Technologies Inc.
Co-Founder and Managing Partner
2015 – 2023
NewLeaf Symbiotics, Inc.
Co-Founder and VP for Intellectual Property (2011 – 2014)
Director
2011 – 2014 · St. Louis, MO
Touro University Jacob D. Fuchsberg Law Center
Adjunct Faculty
2010 – 2012
Stony Brook University College of Business
Adjunct Faculty
2008 – 2010
ipCapital Group
Senior Associate
2005 – 2008

Key Colleagues at Startups

The people Michael Bielski works with at each company, as listed on that company's latest Form D.

Spearhead Bio, Inc. · Form D, Jun 23, 2026
Keith Slotkin
Keith Slotkin
Founder & Chief Scientific Officer, director
Harold Davies
Harold Davies
Chief Financial Officer, DTC and director
Thomas Laurita
Thomas Laurita
CEO of the Danforth Technology and director
Metablify, Inc. · Form D, Jun 6, 2024
Harold Davies
Harold Davies
Executive officer and director
NewLeaf Symbiotics, Inc. · Form D, Jan 18, 2013
MJ
Marcus Jones
Executive officer
RC
MV
Marc Vanacht
Executive officer and director
SK
Stephen Kahn
Chief Financial Officer
MS
Mel Schuster
Director
TL
Thomas Laurita
Executive officer and director

Sources

  1. SECSpearhead Bio, Inc. Form D, filed Jun 23, 2026
  2. SECMetablify, Inc. Form D, filed Jun 6, 2024
  3. SECNewLeaf Symbiotics, Inc. Form D, filed Jan 18, 2013